Viking Therapeutics VKTX Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Viking Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viking Therapeutics's change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viking Therapeutics's change in lease liabilities?
- Viking Therapeutics (VKTX) reported change in lease liabilities of -$139K in Q1 2026.
- How has Viking Therapeutics's change in lease liabilities changed year-over-year?
- Viking Therapeutics's change in lease liabilities decreased by 7.8% year-over-year, from -$129K to -$139K.
- What is the long-term trend for Viking Therapeutics's change in lease liabilities?
- Over 4 years (2021 to 2025), Viking Therapeutics's change in lease liabilities has grown at a 10.2% compound annual growth rate (CAGR), from -$342K to -$505K.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.